Pharmacologic therapy for urticaria

Allergologia et Immunopathologia

Volumn 25, Issue 1, 1997, Pages 36-51

  Negro Alvarez, J M ^a,b   Carreno Rojo A ^a   Funes Vera, E ^a   Garcia Canovas A ^a   Abellan Aleman A F ^a   Rubio Del Barrio, R ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN DE LA ARRIXACA   (Spain)

^b NONE   (Spain)

Author keywords

antihistamines; calcium antagonists; ceterizine; dapsone; doxepin; ebastine; H2 antagonists; loratadine; nonsedating H1 antagonist; urticaria; urticaria treatment

Indexed keywords

ACRIVASTINE; ANDROGEN; ANTIMALARIAL AGENT; ASTEMIZOLE; AZELASTINE; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CALCIUM ANTAGONIST; CETIRIZINE; CHLORPHENIRAMINE; CIMETIDINE; COLCHICINE; CYCLOSPORIN A; CYPROHEPTADINE; DAPSONE; DIPHENHYDRAMINE; DOXANTRAZOLE; DOXEPIN; EBASTINE; GLUCOCORTICOID; GOLD; HISTAMINE H1 RECEPTOR ANTAGONIST; HISTAMINE H2 RECEPTOR ANTAGONIST; HYDROXYZINE; KETOTIFEN; LORATADINE; METHOTREXATE; OXATOMIDE; RANITIDINE; TERFENADINE; UNINDEXED DRUG;

HUMAN; REVIEW; URTICARIA;

CHRONIC DISEASE; HISTAMINE H1 ANTAGONISTS; HISTAMINE H2 ANTAGONISTS; HUMANS; URTICARIA;

EID: 0030896494     PISSN: 03010546     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (220)

1. Ormerod AD Urticaria, Recognition, causes and treatment. Drugs 1994;48:5:717-730.
2. Mathews KP. Management of urticaria and angioedema J Allergy Clin Immunol. 1980;66:5.347-357.
3. Monroe EW Treatment of urticaria Dermatol Clin. 1985;3.51-55.
4. Monroe EW, Jones HE. Urticaria:an update review. Arch Dermatol. 1977;113:80-90.
5. Kennard CD, Ellis CN. Pharmacologic therapy for urticaria J Am Acad Dermatol. 1991,1 (pt 2);176-189.
6. Jacobson KW, Branch LB, Nelson HS. Laboratory tests in chronic urticaria JAMA. 1980;243:1644-1646.
7. Juhlin L Recurrent urticaria:clinical investigation of 330 patients. Br J Dermatol. 1981;104:369-381.
8. Guin JD. The evaluation of patients with urticaria. Dermatol Clin. 1985;3:29-49
9. Green GR, Koelsche GL, Kierlund RR. Etiology and pathogenesis of chronic urticaria. Ann Allergy. 1965,23.30-36.
10. Champion RH, Roberts SOB, Carpenter RG, Roger JH Urticaria and angioedema:a review of 554 patients. Br J Dermatol 1969;81-588-597.
11. Twarog RJ. Urticaria in childhood,pathogenesis and management Pediatr Clin North Am. 1983;30.887-897
12. Kerdel FA, Soter NA. Antihistamines in dermatology In:Rook AJ, Maibach HI, eds. Recent advances in dermatology 6th ed. Edinburgh:Churchill Livingston. 1983.265.
13. Shelly WB. Commentary:antihistamines and the treatment of urticaria. Arch Dermatol 1983;119:442-444
14. Lahti A. Urticaria In.Posgraduate Course in allergological aspects of Dermatology. ICACI XV. EAACI'94 Marion Merrell Dow, Europe, AG. 1994;59-66.
15. Dale HH, Laidlaw PP The physiological action of beta-imidazolyl-ethylamine. J Physiol. 1910,41:318-344.
16. Ash ASF, Schild HO. Receptors mediating some actions of histamine Br J Pharmacol Chemother. 1966;27:427-439.
17. 2 receptors. Nature. 1972;236:385-390.
18. 3-receptors. Nature. 1987;327:117-123.
19. Bovet D. Introduction to antihistamine agents an antergan derivatives. Ann N Y Acad Sci. 1950;50.1089-1126.
20. Staub AM, Bovet D. Action de la thymoxyéthylamine (928F) et des éthers phénoliques sur le choc anaphylactique du cobaye. CR Scéances Soc Biol Fil. 1937,125:818.
21. Yonkman FF, Chess D, Mathieson D, Hansen N. Pharmacodynamic studies of a new antihistamine agent, N′-pyridyl-N′-benzyl-N-dimethyl-ethylene-diamine-HCl, pyribenzamine HCl. I. Effects on salivation, nictitating membrane, lachrymation, pupil and blodd presure. J Pharmacol Exp Ther 1946;87:256
22. Bovet D, Staub AM. Action protectrice des éters phénoliques au cours de l'intoxication histaminique CR Scéances Soc Biol Fil 1937,124.547-549.
23. Halpern BN Les antihistaminiques de syntése. Essai de chimiothérapie des états allergiques Arch Int Pharmacodyn Thér. 1942;68:339-408
24. Bovet D, Horclois R, Wathert F Propiétés antihistaminiques de la N-p-méthoxybenzyl-N-diméthilaminoéthyl-alfa-aminopyridine. CR Scéances Soc Biol Fil. 1944;138.99-100
25. Lowe ER, MacMillan R, Katser ME. The antihistamine properties of Benadryl, b-dimethyl-aminoethyl-benzhydryl ether hydroclhoride J Pharmacol Exp Ther 1946;86:229-238.
26. Flowers FP, Araujo O, Nieves C. Antihistamines. Int J Dermatol 1986,25:224-231
27. Douglas WW Histamine and 5-hydroxytryptamine (serotonin) and their antagonists In Goodman LS, Rall TW, Murad F, eds. Goodman and Gilman's the pharmacologic basis of therapeutics 7th ed New York:Macmillan. 1985;605-638
28. Witiak DT, Lewis NJ. Absorption, distribution, metabolism and elimination of antihistamines In:Rocha E, Silva M, eds. Histamines II and anti-histaminics:chemistry, metabolism and physiological and pharmacological actions. Handbuch der experimentellen Pharmakologie, vol 18. Berlin: Springer-Verlag. 1978:513-560
29. Carruthers SG, Shoeman DW, Hignite CE, Azarnoff DL. Correlation between plasma diphenhydramine level and sedative and antihistamine effects Clin Pharmacol Ther 1978;23:375-382.
30. Schwartz JC. Histaminergic mechanisms in brain. Annu Rev Pharmacol Toxicol 1977;17:325-339.
31. Rocha E, Silva M, Antonio A Bioassay of antihistaminic action In:Rocha E, Silva M, eds Histamines II and antihistamines:chemistry, metabolism and physiologic and pharmacologic actions. Handbuch der experimentellen pharma-kologie; vol 18. Berlin:Springer-Verlag 1978:381-438.
32. Drug facts and comparisons Philadelphia:JB Lippincott. 1989.272-273, 771-774
33. DiPalma JR. Drill's pharmacology in medicine. New York:McGraw-Hill. 1971:1003-1020.
34. Rhoades RB, Leifer KN, Choan R. Suppression of histamine-induced pruritus by three antihistamine drugs J Allergy Clin Immunol. 1975;55:180-185.
35. Galant SP, Bullock J, Wong D. The inhibitory effect of antiallergy drugs on allergen and histamine-induced wheal and flare responses J Allergy Clin Immunol. 1973;51:11-21.
36. Mathews CNA, Kirby JD, James J, Warin RP. Dermographism:reduction in wheal size by chlorpheniramine and hydroxyzine Br J Dermatol. 1973;88:279-282.
37. Moore-Robinson M, Warin RP. Some clinical aspects of cholinergic urticaria Arch Dermatol 1981;117:404-407.
38. Brogden RN, McTavish D. Acrivastine:a review of its pharmacological properties and therapeutic efficacy in allergic rhinitis, urticaria and related disorders [published erratum appears in Drugs. 1991;42:4.639] Drugs 1991;41 6 927-940.
39. Neittaanmaki H, Fraki JE, Gibson JR. Comparison of the new antihistamine acrivastine (BW 825C) versus cyproheptadine in the treatment of idiopathic cold urticaria. Dermatologica. 1988.177:98-103.
40. Neittaanmäki H, Myöhanen T. Fräki JE Comparison of cinnarizine, cyproheptadine, doxepin, and hydroxyzine in treatment of idiopathic cold urticaria:usefulness of doxepin J Am Acad Dermatol 1984;II:483-489.
41. Ormerod AD, Baker R, Watt J, White MI Terfenadine and brompheniramine maleate in urticaria and dermagraphism. Dermatologica. 1986,173:1:5-8
42. Huston DP, Bressler RB, Kaliner M, Sowell LK, Baylor MW Prevention of mast cell degranulation by ketotifen in patients with physical urticarias Ann Intern Med 1986;104 507-510.
43. McClean SP, Arreaza EE, Lett-Brown MA, Grant JA Refractory cholinergic urticaria successfully treated with ketotifen [see comments] J Allergy Clin Immunol. 1989,83:4:738-741.
44. Czarnetzki BM. Ketotifen in cholinergic urticaria. J Allergy Clin Immunol. 1990,86:138-139
45. Martin U, Roemer D. The pharmacologic properties of a new, orally active antianaphylactic compound.ketotifen a benzocycloheptathiphene. Drug Res 1978;28:770-782
46. Craps LP, Ney UM. Ketotifen:current reviews on its mechanism of action and their therapeutic implications. Respiration. 1984;45:411-421.
47. Kuokkanen K. A new antihistamine HC 20-511 compared with dimetinden (Fenistil retard) in the treatment of chronic urticaria. Acta Allergy. 1977;32:316-320.
48. Saihan EM. Ketotifen and terbutaline in urticaria. Br J Dermatol. 1981;104:205-206.
49. Beck HI, Cramers M, Herlin T, Sondergaard I, Zachariae H. Comparison of oxatomide and clemastine in the treatment of chronic urticaria A double blind study Dermatologica. 1985;171:1:49-51
50. Richards DM, Brogden RN, Heel RC, Speight TM, Avery GS Oxatomide. A review of its pharmacodynamic properties and therapeatic efficacy Drugs 1984;27:3:210-231.
51. Church MK, Gradidge CF Inhibition of histamine release from human lung in vitro by antihistamines and related drugs Br J Pharmacol. 1980;69:663-667.
52. Doekx P, Vertommen J, Van Daeie R et al Oxatomide effective in chronic urticaria:a double blind comparison with placebo. Curr Ther Res. 1981,29:510-515
53. Peremans W, Mertens RLJ, Morins J, Campaert H. Oxatomide in the treatment of chronic urticaria:a double-blind placebo-controlled trial. Dermatologica. 1981,162:42-50
54. Nishiyama S, Ohkawara A, Kishiyama K et al. Clinical evaluation of KW-4354 (oxatomide), antiallergic agent, against chronic urticaria. Hifu. 1983;25:125-140
55. Dernaubeuge J, Tenustedt D, Bronx R. Does mast cell protection plus mediator antagonism surpass the effect of a classic antihistamine in the treatment of chronic urticaria Dermatologica. 1982;164:386-394.
56. McTavish D, Sorkin EM Azelastine:a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential. Drugs. 1989;38:778-800.
57. Little MM, Casale TB. Azelastine inhibits IgE-mediated human basophil histamine release. J Allergy Clin Immunol 1989,83:862-865
58. Busse W, Randlev B, Sedgwick J. The effect of azelastine on neutrophil and eosinophil generation of superoxide J Allergy Clin Immunol. 1989;83 400-405.
59. Lai CK, Oilier S. Lau CK, Holgate ST. Effect of azelastine and ketotifen on the bronchial and skin responses to platelet-activating factor in humans Clin Exper Allergy. 1991:21:489-496
60. Friedman BS, Santiago ML, Berkebile C, Metcalfe DD. Comparison of azelastine and chlorpheniramine in the treatment of mastocitosis J Allergy Clin Immunol. 1993;92: 4:520-526.
61. Naclerio RM, Kagey-Sobotka A, Lichtenstein LM, Freidhoff L, Proud D Terfenadine, an HI antihistamine, inhibits histamines release in vivo in the human. Am Rev Respir Dis. 1990;142.167-171.
62. Okerholm RA, Weiner DL, Hook RH et al Bioavailability of terfenadine in man. Biopharm Drug Dispos. 1981,2 185.
63. Huther KJ, Renftle G, Barraud N. Inhibitory activity of terfenadine on histamine-induced skin wheals in man. Eur J Clin Pharmacol. 1977,12:195-199
64. Woodward JK. Pharmacology and toxicology of nonclassical antihistamines. Cutis. 1988;42:5-9
65. Cheng HC, Woodward JK Antihistanic effect of terfenadine:a new piperdine-type antihistamine. Drug Dev Res. 1982;2:181-196.
66. Wiech NL, Martin JS Absence of an effect of terfenadine on guinea pig brain histamine HI-receptors in vivo determined by receptor binding techniques. Arzneimittelforschung. 1982;32 1167-1170.
67. Nabe M, Agrawal DK, Sarmiento EU, Townley RG. Inhibitory effect of terfenadine on mediator release from human blood basophils and eosinophils. Clin Exp Allergy 1989,19: 515-520.
68. Guaglianone MM, Vergallo G, Iudice A, Henauer SA. Once a day dosage of terfenadine in chronic urticaria.a double-blind comparison with the standard dose [Abstract]. Allergy. 1988;43 Supl 7:94
69. Paul E, Reinel D, Ulrich R, Köhler ME. Comparison of efficacy and tolerability of terfenadine administered once daily versus twice daily in patients with chronic idiopathic urticaria [Abstract] Allergy. 1988;43 Supl 7:94.
70. Adessi B, Allegra F, Beaumont D, Bergeron D, Brunett JL, Caperan D et al Terfenadine once daily in chronic urticaria:a multi-centre double-blind comparison of terfenadine once daily versus twice daily. Allergy. 1989;44.447-452.
71. Shall L, Newcombe RG, Marks R. Assessment of the duration of action of terfenadine on histamine induced weals Br J Dermatol 1988 119.525-531.
72. Koh KK, Rim MS, Yoon J, Kim SS. Torsade de pointes induced by terfenadine in a patient with long QT syndrome. J Electrocardiol. 1994;27:4.343-346.
73. Honig PK, Wortham DC, Zamani K, Conner DP, Mullin JC, Cantilena LR. Terfenadine ketoconazole interaction, pharmacokinetic and electrocardiographic consequences. JAMA. 1993;269:12:1513-1518.
74. Grant JA, Bernstein DI, Buckley CE, Chu T, Fox RW, Rocklin RE Double-blind comparison of terfenadine, chlorpheniramine and placebo in the treatment of chronic idiopathic urticaria J Allergy Clin Immunol 1988,81:574-579.
75. Boggs PB, Ellis CN, Grossman J, Washburnz WF, Gupta AK, Ball R et al. Double-blind placebo-controlled study of terfenadine and hydroxyzine in patients with chronic idiopathic urticaria Ann Allergy. 1989;63:616-620.
76. Bilsland D, Ferguson J. A comparison of cetirizine and terfenadine in the management of solar urticaria. Photodermatol Photoimmunol Photomed. 1991;8.2:62-64.
77. Diffey BL, Farr PM. Treatment of solar urticaria with terfenadine. Photodermatol. 1988;5:25-29
78. Negro JM, Sarrió F, Miralles JC, Garcia Sellés FJ, López Sánchez JD, Pagán JA et al Los antihistamimicos no sedantes en el tratamiento de la urticaria crónica. Allergol Immunopathol 1995,23:3:137-144.
79. Cerio R, Lessof MH Treatment of chronic idiopathic urticaria with terfenadine. Clin Allergy. 1984;14.139-141.
80. Krause LB, Shuster S. Recent studies with terfenadine in chronic idiopathic urticaria and dermographic urticaria [Abstract]. Ann Allergy. 1985;55:284.
81. Ferguson J, MacDonal KJS, Kenicer KJA. Terfenadine and placebo compared in the treatment of chronic idiopathic urticaria:a randomized double-blind study. Br J Clin Pharmacol. 1985;20:639-641.
82. Fredriksson T, Hersle K, Hjorth N, Mobacken H, Persson T, Salde L et al. Terfenadine in chronic urticaria:a comparison with clemastine and placebo. Cutis 1986;38 2:128-130.
83. Belaich S, Bruttmann G, De Greef H, Lachapelle JM, Paul E, Pedrali P et al. Comparative effects of loratadine and terfenadine in the treatment of chronic idiopathic urticaria. Ann Allergy. 1990,64:2(Pt2):191-194.
84. Neuman Y. Antihistamine treatment of chronic urticaria:results of a multicenter trial with azatadine and terfenadine Fortschr Med 1984,102.947-970
85. Goldsmith P, Dowd PM The new Hi antihistamines. Treatment of urticaria and other clinical problems. Dermatol Clin. 1993;11:1:87-95.
86. Paul E, Bodeker RH. Comparative study of astemizole and terfenadine in the treatment of chronic idiopathic urticaria. A randomized double blind study of 40 patients. Ann Allergy 1989;62:4:318-320.
87. Cainelli T, Seidenan S, Valsecchi R, Mosca M. Double-blind comparison of astemizole and terfenadine in the treatment of chronic urticaria Pharmacotherapeutica. 1986,4:10:679-686.
88. Craft TM. Torsade de pointes after astemizole overdose. Br Med J 1986:292:660.
89. Simons FE, McMillan JL, Simons KJ A double-blind, single dose, crossover comparison of cetirizine, terfenadine, loratadine, astemizole, and chlorpheniramine versus placebo:suppressive effects on histamine-induced wheals and flares during 24 hours in normal subjects. J Allergy Clin Immunol 1990;86:4(pt1).540-547.
90. Juhlin L, de Vos C, Rihoux JP. Inhibiting effect of cetirizine on histamine-induced and 48/80-induced wheals and flares, experimental dermographism, and cold-induced urticaria. J Allergy Clin Immunol. 1987;80 599-602
91. Kontou-Fili K, Maniatakou G Demaka P, Gonianakis M, Palaiologos G, Aroni K. Therapeutic effects of cetirizine in delayed pressure urticaria.clinicopathologic findings. J Am Acad Dermatol. 1991,24:6 (pt 2).1090-1093
92. Andri L, Senna GE, Betteli C, Givanni S, Andri G, Lombardi C et al. A comparison of the efficacy of cetirizine and terfenadine. A double-blind, controlled study of chronic idiophatic urticaria. Allergy 1993;48:5:358-365.
93. Kietzmann H, Macher E, Rihoux JP, Ghys L Comparison of cetirizine and terfenadine in the treatment of chronic idiopathic urticaria. Ann Allergy. 1990;65:6:498-500.
94. Juhlin L Cetirizine in the treatment of chronic urticaria Clin Ther. 1991;13 1:81-86.
95. Dockx P, Lambert J, Arendt C, Darte D. Comparison of cetirizine and terfenadine in idiophatic urticaria. Rev Esp Alergol Immunol Clin. 1987,2:2.113.
96. Kint A, Constandt L, Arendt C, Bernheim J Comparative efficacy of cetirizine and terfenadine in chronic idiopathic urticaria. Acta Ther 1989;15:65-75.
97. Go MJTh, Wuite J, Arendt C, Bernheim J. Double-blind, placebo controlled comparison of cetirizine and terfenadine in chronic idiophatic urticaria. Acta Ther. 1989;15.77-86.
98. Lambert D, Hartzperg M, Danglas P, Bloom M. Double-blind comparative study of terfenadine and cetirizine in chronic idiophatic urticaria. Allerg Immunol Paris 1993;25:6 235-240.
99. Holgate ST, Goa KL. Astemizole a review of clinical experience. Manchester:Adis Press International Limited. 1988:3-29
100. Krause LB, Shuster S. A comparison of astemizole and chlorpheniramine in dermographic urticaria. Br J Dermatol. 1985,112:447-453.
101. Honsinger RW, Thomsen RJ Prolonged benefit in the treatment of chronic idiopathic unicaria with astemizole Ann Allergy 1990;65:194-200.
102. Richards DM, Brogden RN, Heel RC, Speight TM, Avery GS Astemizole:a review of its pharmacodynamic properties and therapeutic efficacy. Drugs. 1984;28:38-61.
103. Filderman RB, Rosen LJ. Comparison of onset and offset of inhibition of antigen-induced skin wheeling of Seldane (terfenadine), Hismanal (astemizole) and placebo [Abstract]. J Allergy Clin Immunol. 1987;79:190
104. Bateman DN, Chapman PH, Rawlins MD. Effects of astemizole in histamine-induced wheal and flare. Eur J Clin Pharmacol. 1983;25:547-551
105. Murrieta M, Beaumont D, Michelin V, Lynadier F, Dry J. Time course of action of terfenadine and astemizole:a double-blind study on histan-úne and codeine skin tests in volunteers [Abstract] Rev Esp Alergol Inmunol Clin 1987;2:2:138.
106. Astemizole:another non-sedating antihistamine Med Lett. 1989;31:43-44.
107. Craft TM, Van den Bushe GM, De Cree J et al ECG studies with astemizole. Human Toxicol 1987:6:527-528
108. Simons FE. Evolution of Hi receptor antagonist treatment. Ann Allergy. 1993;71:3:282-287.
109. Vanden Bussche G, Emanuel MB, Rombaut N. Clinical profile of astemizole.a survey of 50 double-blind trials. Ann Allergy. 1987;58:184-188.
110. Moscicki RA, Fox R, Kailasam V, Eisen J. Astemizole:steroid-sparing effect in chronic urticaria J Allergy Clin Immunol. 1992;89:249
111. Bernstein IL, Bernstein DI Efficacy and safety of astemizole, a long-acting and non-sedating Hi antagonist for the treatment of chronic idiopathic urticaria J Allergy Clin Immunol. 1986;77:37-42
112. Fox RW, Lockey RF, Bukantz SC, Serbousek D. The treatment of mild to servere chronic idiopathic urticaria with astemizole double blind and open trials. J Allergy Clin Immunol 1986;78:1159-1166.
113. Kailasam V, Mathews KP. Controlled clinical assessment of astemizole in the treatment of chronic idiopathic urticaria and angioedema. J Am Acad Dermatol. 1987,16 4:797-804.
114. Simons FER, Kesselman MS, Giddins NG, Pelech AN, Simons KJ Astemizole induced torsade de pointes. Lancet 1988;2:624.
115. Snook J, Boothman-Burrell D, Watkins J, Cohn-Jones D. Torsade de pointes ventricular tachycardia associated with astemizole overdose. Br J Clin Pract. 1988;42:6:257-259
116. Damseaux M, Lapachelle JM, DeWeert J et al. Astemizole in the treatment of chronic urticaria.a double blind multicentric study Clin Res 1981;43:1.
117. 1 antagonist. Oxford Medical Education Services 1984;94-100.
118. 1 antagonists in the treatment of chronic idiopathic urticaria. Ann Allergy. 1991;67:4:433-439.
119. Alomar A, De la Cuadra J, Fernández J. Cetirizine vs astemizole in the treatment of chronic idiopathic urticaria. J Int Med Res. 1990;18:5:358-365.
120. Monfrecola G, Nappa P, Pini D. Solar urticaria in the visible spectrum successfully treated with with astemizole Dermatologica. 1990;180.3:154-156.
121. Breneman D, Bronsky EA, Bruce S, Kalivas JT, Klein GL, Roth HL et al. Cetirizine and astemizole therapy for chronic idiophatic urticaria:a double-blind, placebo-controlled, comparative trial. J Am Acad Dermatol. 1995;33:2 (Pt 1):192-198
122. Wiseman LR, Faulds D Ebastina Revisión de sus propiedades farmacológicas y de su eficacia clinica en el tratamiento de procesos alérgicos. Drug. 1996,51.2:260-277
123. Barnett A, Iorio LC, Kreutner W, Tozzi S, Ahn HS, Gulbenkian A. Evaluation of the CNS properties of SCH 29851, a potential non-sedating antihistamine Agents Actions 1984;14:590-597
124. Kassem NY, Garvin PR, Gural RP, Amkraut HJ Inhibition of histamine-induced wheals by SCH 29851 [Abstract]. Ann Allergy 1985;54:366.
125. Kassem N, Roman I, Gural R, Dyer G, Robillard N. Effects of loratadine (SCH 29851) in suppression of histamine-induced skin wheals Ann Allergy. 1988,60:505-507.
126. Katchen B, Cramer J, Chung M, Gural R, Hilbert J, Luc V et al. Disposition of 14C-SH 29851 in humans. [Abstract 669] Ann Allergy. 1985;55(pt 2):393.
127. Friedman HM Loratadine.a potent, nonsedating, and long-acting HI antagonist Am J Rhinol. 1987;1:95-99.
128. Clissold SP, Sorkin EM, Goa KL Loratadine. A preliminary review of its pharmacodynamic properties and therapeutic efficacy Drugs. 1989;37:42-57.
129. Soter NA Treatment of urticaria and angioedema.low-sedating H1-type antihistamines. J Am Acad Dermatol. 1991,24.6 (Pt 2) 1084-1087.
130. Paul E. Treatment of pruritic skin diseases with loratadine. Results of an open multicenter study. Fortschr Med. 1991; 109: 7 175-178.
131. Pacor ML, Biasi D, Girelli D, Cortina P, Corrocher R. Effectiveness of loratadine vs placebo in the treatment of urticaria-angioedema in patients with food allergy. Clin Ther. 1993,142. 6:529-532.
132. Dominguez-Soto L, Saraceno E, Falabella R. Comparative effects of loratadine and terfenadine in the treatment of chronic idiopathic urticaria. Presented at the Seventeenth World Congress of Dermatology, West Berlin, May. 1987
133. Drovin M, Hebert J, Madden WS et al The safety and efficacy of loratadine in the management of idiopathic chronic urticaria Presented at the Seventeenth World Congress of Dermatology, West Berlin, May 1987
134. Abu Shareeah AM. Comparative efficacy of loratadine and terfenadine in the treatment of chronic idiopathic urticaria. Int J Dermatol 1992;31:5:355-356
135. Haria M, Fitton A, Peters DH. Loratadine. A reappraisal of its pharmacological properties and therapeutic use in allergic disorders. Drugs 1994,48:4:617-637.
136. 1 en el manejo de dermatosis cronicas pruriginosas Dermatol Rev Mex. 1987;31:9-14.
137. Monroe EW Nonsedating HI antihistamines in chronic urticaria. Ann Allergy 1993,71:6:585-591
138. Monroe EW. Relative efficacy and safety of loratadine, hydroxyzine, and placebo in chronic idiopathic unicaria and atopic dermatitis. Clin Ther 1992;14.1 17-21.
139. Monroe EW, Bernstein DI, Fox RW, Grabiec SV, Honsinger RW, Kalivas JT et al. Relative efficacy and safety of loratadine, hidroxicine, and placebo in chronic idiophatic urticaria. Arzneimittelforschung. 1992;42:9:1119-1121.
140. Pechadre JC, Beudin R, Eschalier A, Trolese JF, Rihoux JP. A comparison of central and peripheral effects of cetirizine and loratadine J Int Med Res. 1991;19:4:289-295
141. Temple DM, McCluskey M. Loratadine an antihistamine blocks antigen and ionophore induced leukotriene release from human lung in vitro. Prostaglandins. 1988;35:549-554.
142. Andersson M, Nolte H, Baumgarten C, Pipkorn U Suppresive effect of loratadine on allergen-induced histamine release in the nose Allergy. 1991;46.540-546.
143. Monroe EW, Fox RW, Green AW, Izuno GT, Bernstein DI, Pleskow WW et al. Efficacy and safety of loratadine (10 mg once-daily) in the management of idiopathic chronic urticaria J Am Acad Dermatol. 1988;19:138-139
144. Bernstein IL, Bernstein DI. The efficacy and safety of loratadine in the management of chronic idiopathic urticaria. J Allergy Clin Immunol. 1988;81.211.
145. Pedrali P, Bruttman G Efficacy of loratadine in the management of idiopathic chronic urticaria Abstract. Presented at the XIII Congress of the European Academy of Allergology and Clinical Immunology Budapest. 1986
146. Paul E. Loratadine and terfenadine in the treatment of chronic urticaria. Results of a multicentre study. Allergy. 1988;43 Supl 7:122
147. Pleskow WW. Studies of a new antihistamine in the management of perennial allergic rhinitis and chronic idiopathic urticaria. Presentado en el 44th Annual Congress American College of Allergist Boston. 1987.
148. Villas Martinez F, Contreras FJ, López Canaza JM, López Serrano MC, Martinez Alzamora F. A comparison of new non-sedaring and classical antihistamines in the treatment of primary acquired cold urticaria (ACU). J Invest Allergol Clin Immunol. 1992,2:5:258-262.
149. Randazzo L, Valencia M, Olivé-Pérez A. Comparison between cetirizine and terfenadine-time response study. Allergol Immunopathol. 1992;20 119-123.
150. Campoli-Richards DM, Buckley MM, Fitton A. Cetirizine a review of its pharmacological properties and clinical potential in allergic rhinitis, pollen-induced asthma, and chronic urticaria. Drugs. 1990;40;5.762-781
151. 1 antagonist with antieosinophilic activity in chronic urticaria J Am Acad Dermatol. 1991:25:668-674.
152. 1 antagonism in allergic inflammation J Allergy Clin Immunol. 1990;86:1019-1024.
153. Kalivas J, Breneman D, Tharp M, Bruce S, Bigby M. Urticaria:clinical efficacy of cetirizine in comparison with hydroxyzine and placebo J Allergy Clin Immunol. 1990;86:6(Pt2): 1014-1018.
154. 1 antagonists alone Br J Dermatol. 1993;129 5:575-579.
155. Sharpe GR, Shuster S. The effect of cetirizine on symptoms and wealing in dermographic urticaria. Br J Dermatol. 1993,129.5:580-583.
156. Ghys L, Rihoux JP. Pharmacological modulation of cutaneous reactivity to histamine, a double blind comparative study between cetirizine, terfenadine and astemizole. J Int Med Res 1989;17:24-27.
157. Goh CL, Wong WK, Lim J Cetirizine vs placebo in chronic idiopathic urticaria A double-blind randomised cross-over study Ann Acad Med Singapore. 1991;20:3:328-330
158. Tadmor B, Rubinow A, Shalit M. Delayed pressure urticaria.therapeutic response to cetirizine Harefuah 1993,124:11:683-685
159. Zuberbier T, Aberer W, Burtin B, Rihoux JP, Czarnetzki BM. Efficacy of cetirizina in cholinergic urticaria. Acta Derm Venereol 1995;75 2:147-149.
160. Marks P, Manna VK, Gibson JR. Acrivastine an evaluation of initial and peak activity in human skin. J Int Med Res 1989,17 Supl 2:3B-8B
161. Gale AE, Harvey SG, Calthrop JG, Gibson JR A comparison of acrivastine versus chlorpheniramine in the treatment of chronic idiopathic unicaria. J Int Med Res 1989,17 Supl 2 25B-27B.
162. Leyh F, Harvey SG, Gibson JR, Manna VK. A comparison of acrivastine versus clemastine and placebo in the treatment of patients with chronic idiopathic urticaria. J Int Med Res. 1989;17 Supl 2:22B-24B.
163. Salo OR, Harvey SG, Calthrop JG, Gibson JR. A comparison of acrivastine versus hydroxyzine and placebo in the treatment of chronic idiopathic urticaria. J Int Med Res 1989;17 Supl 2:18B-21B
164. Juhlin L, Gibson JR, Harvey SG, Huson LW Acrivastine versus clemastine in the treatment of chronic idiopathic urticaria A double-blind, placebo-controlled study. Int J Dermatol. 1987;26:10:653-654.
165. Kobza Black A, Aboobaker J, Gibson JR, Harvey SG, Marks P Acrivastine versus hydroxyzine in the treatment of cholinergic urticaria.a placebo-controlled study Acta Derm Venereol 1988;68:541-544.
166. Boyle J, Marks P, Gibson JR. Acrivastine versus terfenadine in the treatment of symptomatic dermographism - a double-blind, placebo-controlled study. J Int Med Res. 1989,17 Supl 2.9B-13B
167. Figueiredo A, Fontes-Ribeiro CA, Gonçalo M, Almeida L, Poiares-Baptista A, Teixeira F Mechanism of action of doxepin in the treatment of chronic urticaria. Fundam Clin Pharmacol. 1990:4:147-158.
168. 1 receptors Mayo Clin Proc. 1979;54:669-674.
169. Greene SL, Reed CE, Schroeter AL. Double-blind crossover study comparing doxepin with diphenhydramine for the treatment of chronic urticaria. J Am Acad Dermatol. 1985:12: 669-675.
170. Golsobel AB, Rohr AS, Siegel SC, Spector SL, Katz RM, Rachelefsky GS et al. Efficacy of doxepin it the treatment of chronic idiopathic urticaria. J Allergy Clin Immunol. 1986 78.5 Pt. 1:867-873.
171. Robertson I, Greaves MW. Responses of human skin blood vessels to synthetic histamine analogues. Br J Clin Pharmacol. 1978;5:319-322
172. 2-receptor blocking agent. Br J Clin Pharmacol. 1977;4:367-369.
173. 2)-receptor antagonists in the treatment of urticaria Drugs. 1989;37:345-355.
174. 2 receptor antagonists on the dermagraphic response. Acta Derm Venereol. 1983,63.260-262
175. 2 histamine antagonists on symptomatic dermographism. Br J Dermatol. 1979;101:57-61.
176. 2 antagonists. Ann Allergy. 1983;50.264-265
177. Farnam J, Grant JA, Guernsey BG, Jorizzo JL, Petrusa ER. Successful treatment of chronic idiopathic urticaria and angioedema with cimetidine alone. J Allergy Clin Immunol 1984,73:842-845.
178. 2 antagonists:a case report. Ann Allergy 1986,56:355-357.
179. Tokura Y, Takigawa M, Yamauchi T, Yamada M Solar urticaria:a case with good therapeutic response to cimetidine. Dermatalogica. 1986;173:5:224-228
180. Commens CA, Greaves MW. Cimetidine in chronic idiopathic urticaria:a randomized double-blind study Br J Dermatol. 1978;99:675-679.
181. Cook LJ, Shuster S. Lack of effect of cimetidine in chronic idiopathic urticaria. Acta Derm Venereol. 1983,63:265-267
182. 2 antagonists:a cross over double-blind long-term study. Z Hautkr. 1983;58:785-793.
183. Harvey RP, Wegs J, Schoeket AL A controlled trial of therapy in chronic urticaria. J Allergy Clin Immunol 1981 ,68:262-266.
184. 2 blockers in chronic urticaria. Int J Dermatol. 1984,23.627-628.
185. 2 antihistamine therapy in chronic urticaria. Arch Dermatol. 1981;117:404-407.
186. Bleehen SS, Thomas SE, Greaves MW Newton J, Kennedy CT, Hindley F et al. Cimetidine and chlorpheniramine in the treatment of chronic idiopathic urticaria.a multi-centre randomized double-blind study Br J Dermatol. 1987;117.1.81-88
187. Paul E, Bodeker RH. Treatment of chronic urticaria with terfenadine and ranitidine:a randomized double-blind study in 45 patients Eur J Clin Pharmacol 1986;31:277-280
188. 2 blockers. Clin Allergy. 1978;8:429-433.
189. Salo OP, Kauppinen K, Mannisto PT. Cimetidine increases the plasma concentration of hydroxyzine Acta Derm Venereol 1986.66 349-350
190. Moscati RM, Moore GP. Comparison of cimetidine and diphenhydramine in the treatment of acute urticaria. Ann Emerg Med. 1990;19:1:12-15.
191. Runge JW, Martínez JC, Caravati EM, Williamson SG, Hartsell SC. Histamine antagonists in the treatment of acute allergic reactions. Ann Emerg Med. 1992,21:3:237-242.
192. 2-antagonists (Altramet) in chronic/chronically-recurrent urticaria Dermatol Monaisschr 1990;176:11:653-659.
193. 1 antagonists hydroxyzine and cetirizine in patients with chronic urticaria. J Allergy Clin Immunol. 1995; 95:3.685-693.
194. Bressler RB, Sowell K, Huston DP Therapy of chronic idiopathic urticaria with nifedipine:demonstration of beneficial effect in a double-blinded, placebo-controlled, crossover trial. J Allergy Clin Immunol. 1989 83:756-763.
195. Lawlor F, Ormerod AD, Greaves MW. Calcium antagonist in the treatment of symptomatic dermographism:low-dose and high-dose studies with nifedipine. Dermatologica. 1988,177 287-289.
196. Pigatto PD, Fumagalli M, Bigardi A, Altomare G, Finzi AF Nimodipine versus terfenadine in the treatment of physical stimulus-induced urticaria Allergy 1990,45:1:71-74.
197. Brestel EP, Thrush LB. The treatment of glucocorticosteroid dependent chronic urticaria with stanozolol. J Allergy Clin Immunol. 1988,82:265-269.
198. Ormerod AD, Smart L, Reid TM, Milford-Ward A. Famililial cold urticaria-investigation of a family and response to stanozolol Arch Dermatol. 1993;129:343-346.
199. Zip CM, Ross JB, Greaves MW, Scriver CR, Mitchell JJ, Zoar S. Familial cold urticaria. Clin Exper Dermatol. 1993;18:4:338-341.
200. Wong E, Eftekhari N, Greves MW, Ward AM Beneficial effects of danazol on symptoms and laboratory changes in cholinergic urticaria. Br J Dermatol. 1987;116:4:553-556.
201. Midelfart K, Moseng D, Kavli G, Stenvold SE, Volden G. A case of chronic urticaria and vitiligo, associated with thyroiditis, treated with PUVA. Dermatologica. 1983;167.1 39-41
202. Logan RA, O'Briett TJ, Greaves MW. The effect of psoralen photochemotherapy (PUVA) on symptomatic dermographism. Clin Exper Dermatol 1989;14:25-28
203. Johnsson M, Falk ES, Volden G. UVB treatment of factitious urticaria. Photodermatol. 1987;4:302-304
204. Olafsson JH, Larko O, Roupe G, Granerus G, Bengtsson U. Treatment of chronic urticaria with PUVA or UVA plus placebo:a double-blind study. Arch Dermatol Res. 1986,278:3:228-231.
205. Fortson JS, Zone JJ, Hammond ME, Groggel GC Hypocomplementemic urticarial vasculitis syndrome responsive to dapsone. J Am Acad Dermatol. 1986;15:1137-1142.
206. Muramatsu C, Tanabe E. Urticarial vasculitis:response to dapsone and colchicine [letter]. J Am Acad Dermatol. 1985;13:1055
207. Dayani A, Gould DL, Campbell S Delayed pressure urticaria, treatment with dapsone. J Dermatol Treat. 1992;3.61-62.
208. Holtman JH, Neustandt DH, Klein J, Callen JP. Dapsone is an effective therapy for the skin lesions of subacute cutaneous lupus erythematosus and urticarial vasculitis in a patient with C2 deficiency J Rheumatol 1990;17:9:1222-1225.
209. Nurnberg W, Grabbe J, Czarnetzki BM Urticarial vasculitis syndrome effectively treated with dapsone and pentoxifylline. Acta Derm Venereol. 1995;75:1.54-56
210. Kennes B, De Maubeuge J, Delespesse G. Treatment of chronic urticaria with a b2-adrenergic stimulant Clin Allergy. 1977;7.35-39.
211. Spangler DL, Vanderpool GE, Carroll MS, Tinkelman DG. Terbutaline in the treatment of chronic urticaria. Ann Allergy 1980;45 246-247.
212. Husz S, Toth-Kasa I, Kiss M, Dobozy A.Treatment of cold urticaria Int J Dermatol 1994;33:3:210-213
213. Bentley-Phillips CB, Eady RA, Greaves MW Cold urticaria inhibition of cold-induced histamine release by doxantrazole J Invest Dermatol. 1978,266-268.
214. Juhlin L, Landor M Drug therapy for chronic urticaria. Clin Rev Allergy. 1992,10:349-369.
215. Goupille P, Pizzuti P, Diot E, Jattiot F, Guilmot JL, Valat JP. Schnitzler's syndrome (urticaria and macroglobulinemia) dramatically improved with corticosteoids. Clin Exp Rheumatol. 1995;13.1:95-98
216. Fradin MS, Ellis CN, Goldfarb MT, Voorhees JJ. Oral cyclosporine for severe chronic idiopathic urticaria and angioedema. J Am Acad Dermatol. 1991;25:1065-1067
217. Stellato C, De Paulis A, Ciccarelli A. Anti-inflammatory effect of cyclosporine A on human skin mast cells. J Invest Dermatol 1993;98:800-804.
218. Asherson RA, Buchanan N, Kenwright S, Fletcher CM, Hughes GR. The normocomplementemic urticarial vasculitis syndrome. Report of a case and response to colchicine. Clin Exp Dermatol 1991;16:6.424-427
219. Gupta MA, Gupta MA Chronic idiopathic urticaria associated with panic disorder a syndrome responsive to selective serotonin reuptake inhibitor antidepressants? Cutis. 1995;56:1:53-54.
220. Shertzer CL, Lookingbill DP. Effects of relaxation therapy and hypnotizability in chronic urticaria. Arch Dermatol. 1987;123:913-916.